Literature DB >> 8793932

Editorials and conflicts of interest.

M Angell, J P Kassirer.   

Abstract

Keywords:  Biomedical and Behavioral Research; New England Journal of Medicine

Mesh:

Substances:

Year:  1996        PMID: 8793932     DOI: 10.1056/NEJM199610033351410

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Guidelines for advertising on health web sites: who's guarding the Koop.

Authors:  M K Cho
Journal:  West J Med       Date:  2000-04

2.  Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy.

Authors:  Athina Tatsioni; George C M Siontis; John P A Ioannidis
Journal:  J Gen Intern Med       Date:  2010-04-28       Impact factor: 5.128

3.  The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors:  O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

4.  Beyond conflict of interest. Transparency is the key.

Authors:  R Smith
Journal:  BMJ       Date:  1998-08-01

5.  Beyond conflict of interest. What is truth as it relates to albumin?

Authors:  O Dearlove
Journal:  BMJ       Date:  1999-02-13

6.  Obesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorship.

Authors:  John M McPartland
Journal:  PLoS One       Date:  2009-03-31       Impact factor: 3.240

7.  Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents.

Authors:  Kevin P Weinfurt; Damon M Seils; Janice P Tzeng; Li Lin; Kevin A Schulman; Robert M Califf
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.